← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 31, 2017Last known activity
May 15, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT04528927Reponsible party - principal investigatorPhase 3May 15, 2020
- NCT04528927Lead sponsorPhase 3May 15, 2020
- NCT04361032Reponsible party - principal investigatorPhase 3May 4, 2020
- NCT04361032Lead sponsorPhase 3May 4, 2020
- NCT04349228Overall official - principal investigatorPhase 3Apr 15, 2020
- NCT04349228Reponsible party - principal investigatorPhase 3Apr 15, 2020
- NCT04351919Reponsible party - principal investigatorPhase 4Apr 15, 2020
- NCT04351919Lead sponsorPhase 4Apr 15, 2020
- NCT04349228Lead sponsorPhase 3Apr 15, 2020
- NCT03752931Lead sponsorPhase 2Dec 31, 2018
- NCT03752931Overall official - principal investigatorPhase 2Dec 31, 2018
- NCT03752931Reponsible party - principal investigatorPhase 2Dec 31, 2018
- NCT03385135Study chairN/ADec 31, 2017
Details
- Last known activity
- May 15, 2020